...
首页> 外文期刊>Molecular BioSystems >Deciphering the cross-talking of human competitive endogenous RNAs in K562 chronic myelogenous leukemia cell line
【24h】

Deciphering the cross-talking of human competitive endogenous RNAs in K562 chronic myelogenous leukemia cell line

机译:解读人竞争性内源性RNA在K562慢性粒细胞性白血病细胞系中的串扰

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by increased proliferation or abnormal accumulation of granulocytic cell line without the depletion of their capacity to differentiate. A reciprocal chromosomal translocation proceeding to the 'Philadelphia chromosome', involving the ABL proto-oncogene and BCR gene residing on Chromosome 9 and 22 respectively, is observed to be attributed to CML pathogenesis. Recent studies have been unraveling the crucial role of genomic 'dark matter' or the non-coding repertoire in cancer initiation and progression. The intricate cross-talk between competitive endogenous RNAs (ceRNAs) provides a scaffold to systematically functionalize the miRNA response element harboring non-coding RNAs and incorporate them with the protein-coding RNA dimension in complex ceRNA networks. This network of coding and non-coding transcriptome linked by shared miRNAs evidently offers a platform to elucidate the complex regulatory interactions at the post-transcriptional level in human cancers. In this context, analyzing CML, from the perspective of the ceRNA hypothesis, surely craves intensive attention and a comprehensive discussion. Here, we performed RNA-seq data analysis to retrieve Lymphoblastoid and CML coding as well as non-coding repertoire and constructed a ceRNA network for the CML cell line, considering the non-cancer lymphoblastoid cell line as the control. We investigated if any alteration exists in the ceRNA landscape of the transcripts which are exhibiting differential expression across the two cell lines and observed that the major ceRNA regulators vary in cancer network when compared with the Lymphoblastoid network. The top ranked significant functional modules in the ceRNA network display cancer associated attributes and reveal putative regulators in CML pathogenesis.
机译:慢性粒细胞性白血病(CML)是一种骨髓增生性疾病,其特征在于粒细胞细胞系的增殖增加或异常积累,而没有耗尽其分化能力。据观察,进行到“费城染色体”的相互染色体易位,涉及分别位于9号和22号染色体上的ABL原癌基因和BCR基因,归因于CML发病机理。最近的研究揭示了基因组“暗物质”或非编码库在癌症发生和发展中的关键作用。竞争性内源性RNA(ceRNA)之间的错综复杂的串扰提供了一个支架,以系统化功能化包含非编码RNA的miRNA响应元件,并将它们与蛋白质编码RNA维度整合到复杂的ceRNA网络中。由共享的miRNA连接的编码和非编码转录组的这种网络显然提供了一个平台,可以阐明人类癌症在转录后水平上的复杂调控相互作用。在这种情况下,从ceRNA假设的角度分析CML无疑会引起广泛的关注和广泛的讨论。在这里,我们进行了RNA-seq数据分析,以检索淋巴母细胞和CML编码以及非编码库,并以非癌性淋巴母细胞为对照,构建了CML细胞系的ceRNA网络。我们调查了转录本的ceRNA格局中是否存在任何改变,这些改变在两种细胞系中均表现出差异表达,并且观察到与lymphoblastoid网络相比,主要的ceRNA调节剂在癌症网络中存在差异。 ceRNA网络中排名最高的重要功能模块显示了与癌症相关的属性,并揭示了CML发病机理中的假定调节因子。

著录项

  • 来源
    《Molecular BioSystems》 |2016年第12期|3633-3642|共10页
  • 作者单位

    Bioinformatics Centre, Bose Institute, P 1/12, C.I.T. Scheme Ⅶ M, Kolkata-700 054, India;

    Bioinformatics Centre, Bose Institute, P 1/12, C.I.T. Scheme Ⅶ M, Kolkata-700 054, India;

    Bioinformatics Centre, Bose Institute, P 1/12, C.I.T. Scheme Ⅶ M, Kolkata-700 054, India;

    Bioinformatics Centre, Bose Institute, P 1/12, C.I.T. Scheme Ⅶ M, Kolkata-700 054, India;

    Bioinformatics Centre, Bose Institute, P 1/12, C.I.T. Scheme Ⅶ M, Kolkata-700 054, India;

    Bioinformatics Centre, Bose Institute, P 1/12, C.I.T. Scheme Ⅶ M, Kolkata-700 054, India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号